March 28, 2023

Volume XIII, Number 87


Azim Chowdhury

Azim Chowdhury joined Keller and Heckman in 2010 and practices in the area of food, drug, and tobacco law. 

Mr. Chowdhury advises domestic and foreign corporations in matters of FDA and international regulatory compliance. In particular, he assists corporations in establishing clearances for food and drug additives in the U.S., Canada, and the European Union, with an emphasis on indirect additives used in food-contact materials.  Mr. Chowdhury has also developed expertise in tobacco and e-vapor product regulation relating to the implementation of the Family Smoking Prevention and Tobacco Control Act, and spearheaded the FDA Tobacco and Electronic Cigarette practice at Keller and Heckman.  Specifically, Mr. Chowdhury has experience representing tobacco, e-cigarette and e-liquid manufacturers, suppliers and trade associations in matters of FDA regulatory and corporate compliance.

Mr. Chowdhury is also a frequent contributor to the Food and Drug Law Institute's (FDLI) Update Magazine, has served on the Editorial Advisory Board of the Food and Drug Law Journal, and has authored and edited numerous articles and publications, including Tobacco Regulation and Compliance: An Essential Resource, FDA Regulation of Tobacco: A Comprehensive Guide – An FDLI Primer and Tobacco and Nicotine Delivery: Regulation and Compliance, 2nd Edition. He frequently speaks at industry conferences and events, was featured in U.S. News and World Reports Best Lawyers Edition(2016) and was named one of “10 Names to Know in the Vape World” in the October 2015 issue of Vape Magazine

Mr. Chowdhury also has an active pro bono practice through Keller and Heckman’s Pro Bono Program and has been featured in the Baltimore Sun for successfully obtaining asylum in the United States for a family who fled their home country of El Salvador because of violence they faced from an international gang.

Articles in the National Law Review database by Azim Chowdhury


 Keller and Heckman LLP has been named a Go-To Thought Leader in the category of Biotech, Food, and Drug Law for 2022. Providing timely analysis on the topic of synthetic nicotine regulation in the United States, authors Azim Chowdhury, Neelam Gill, and Josephine Hsu article reached approximately 100,000 readers, demonstrating the extremely high quality of their thought leadership, as well as their authority regarding the FDA’s recent rulemaking. As the nicotine regulation landscape continues to change, the authors’ analysis serves as a valuable guide for attorneys and industry professionals.

The National Law Review Recognizes  Keller and Heckman’s  Food and Drug Law Practice Group as Go-To Thought Leaders for the firm’s contributions on FDA Regulations and guidelines. Keller and Heckman’s expansive FDA coverage included: proposed rules expanding food traceability and record-keeping requirements, new guidance for animal food additives, a final rule concerning gluten-free food labeling, and approval of a new peanut allergy drug.  Addressing the COVID-19 crisis, Keller & Heckman provided news about warnings required by the FDA for Purell and other actions about hand sanitizer and additional Coronavirus prevention and cure claims, the FDA’s and OSHA’s employee health and food safety checklist(s) and COVID-19 best practices for retail and restaurants and COVID-19 Guidance to U.S. food exporters. The firm’s most frequent FDA / Food and Drug Law attorney contributors to the NLR include Azim Chowdhury, Sheila A. Millar, Evangelia Pelonis, Natalie Rainer and LieAnn Van-Tull.


Azim Chowdhury and his coverage of Vaping Regulations and the FDA has been selected for a National Law Review Go-To Thought Leadership Award. Mr. Chowdhury’s consistent coverage of the emerging issues surrounding Vaping and E-cigarettes, especially his more recent work on the FDA’s push on teen and youth smoking, provides NLR readers with an understanding and analysis of an area that seems to be constantly shifting. You can see his work on Keller and Heckman’s blog on Vaping & the Tobacco Industry, Continuum of Risk.